Perbak Capital Partners’s Oracle ORCL Stock Holding History

Perbak Capital Partners’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,560	Closed	-$341K	–	365
2025 Q2	$341K	Buy	+1,560	New	+$252K	0.08%	229

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Perbak Capital Partners's ORCL Position: Q3 2025 in Review

Perbak Capital Partners sold out of Oracle (ORCL) in Q3 2025, closing a stake of 1,560 shares — an estimated $341K sold.

Perbak Capital Partners first reported a position in ORCL in Q2 2025 and held it in 1 quarter. The position peaked at $341K in Q2 2025. 3,820 funds tracked by Wall St. Rank hold ORCL as of Q3 2025.

Perbak Capital Partners reported no remaining Oracle position as of Q3 2025 after selling out during the quarter.
Perbak Capital Partners sold 1,560 Oracle shares in Q3 2025, an estimated $341K.
Perbak Capital Partners first reported a position in Oracle in Q2 2025 and held it in 1 quarter.
Perbak Capital Partners's Oracle position peaked at $341K in Q2 2025.
3,820 funds tracked by Wall St. Rank held Oracle as of Q3 2025.

Based on Perbak Capital Partners's 13F filing for Q3 2025, filed 13 Nov 2025.